Lu Lu; Qinghui Meng; Ming Cui; Xiaofei Chu; Shuyi Zhao; Huiwen Xiao; Jiali Dong; Eliot Marty Rosen; Saijun Fan; Lu Lu; Qinghui Meng; Ming Cui; Xiaofei Chu; Shuyi Zhao; Huiwen Xiao; Jiali Dong; Eliot Marty Rosen; Saijun Fan

doi:10.3760/cma.j.issn.1673-4114.2016.02.001

[1]

Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015[J]. CA Cancer J Clin, 2016, 66(2):115-132. DOI:10.3322/caac.21338.

[2]

Tsao AS, Scagliotti GV, Bunn PA Jr, et al. Scientific Advances in Lung Cancer 2015[J/OL]. J Thorac Oncol, 2016[2016-03-01]. http://www.ncbi.nlm.nih.gov/pubmed/27013409. DOI: 10.1016/j.jtho.2016.03.012.

[3]

Cheng YW, Lin FC, Chen CY, et al. Environmental exposure and HPV infection may act synergistically to induce lung tumorigenesis in nonsmokers[J/OL]. Oncotarget, 2016[2016-03-01]. http://www.ncbi.nlm.nih.gov/pubmed/?term=26918347. DOI: 10.18632/oncotarget.7628.

[4]

Bae JM, Kim EH. Human papillomavirus infection and risk of lung cancer in never-smokers and women: an 'adaptive' meta-analysis[J/OL]. Epidemiol Health, 2015, 37: e2015052[2016-03-01]. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4722221. DOI: 10.4178/epih/e2015052.

[5]

Bae JM. Modifiable risk factors of lung cancer in "never-smoker" women[J/OL]. Epidemiol Health, 2015, 37: e2015047[2016-03-01]. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4722226. DOI: 10.4178/epih/e2015047.

[6]

Zhai K, Ding J, Shi HZ. HPV and lung cancer risk: a meta-analysis[J/OL]. J Clin Virol, 2015, 63: 84-90. DOI: 10.1016/j.jcv.2014.09.014.

[7]

Ragin C, Obikoya-Malomo M, Kim S, et al. HPV-associated lung cancers:an international pooled analysis[J]. Carcinogenesis, 2014, 35(6):1267-1275. DOI:10.1093/carcin/bgu038.

[8]

Yu Y, Liu X, Yang Y, et al. Effect of FHIT loss and p53 mutation on HPV-infected lung carcinoma development[J]. Oncol Lett, 2015, 10(1):392-398. DOI:10.3892/ol.2015.3213.

[9]

Zhang Y, Fan S, Meng Q, et al. BRCA1 interaction with human papillomavirus oncoproteins[J]. J Biol Chem, 2005, 280(39):33165-33177. DOI:10.1074/jbc.M505124200.

[10]

Barker HE, Paget JT, Khan AA, et al. The tumour microenvironment after radiotherapy:mechanisms of resistance and recurrence[J]. Nat Rev Cancer, 2015, 15(7):409-425. DOI:10.1038/nrc3958.

[11]

Drigotas M, Affolter A, Mann WJ, et al. Reactive oxygen species activation of MAPK pathway results in VEGF upregulation as an undesired irradiation response[J]. J Oral Pathol Med, 2013, 42(8):612-619. DOI:10.1111/jop.12056.

[12]

Gao X, Zhao Y, Stemmer-Rachamimov AO, et al. Anti-VEGF treatment improves neurological function and augments radiation response in NF2 schwannoma model[J]. Proc Natl Acad Sci USA, 2015, 112(47):14676-14681. DOI:10.1073/pnas.1512570112.

[13]

Ciccarelli C, Vulcano F, Milazzo L, et al. Key role of MEK/ERK pathway in sustaining tumorigenicity and in vitro radioresistance of embryonal rhabdomyosarcoma stem-like cell population[J/OL]. Mol Cancer, 2016, 15(1): 16[2016-03-01]. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4761200. DOI: 10.1186/s12943-016-0501-y.

[14]

Provencio M, Sánchez A. Therapeutic integration of new molecule-targeted therapies with radiotherapy in lung cancer[J]. Transl Lung Cancer Res, 2014, 3(2):89-94. DOI:10.3978/j.issn.2218-6751. 2014.03.06.

[15]

Marullo R, Werner E, Zhang H, et al. HPV16 E6 and E7 proteins induce a chronic oxidative stress response via NOX2 that causes genomic instability and increased susceptibility to DNA damage in head and neck cancer cells[J]. Carcinogenesis, 2015, 36(11):1397-1406. DOI:10.1093/carcin/bgv126.

[16]

Tsang NM, Nagasawa H, Li C, et al. Abrogation of p53 function by transfection of HPV16 E6 gene enhances the resistance of human diploid fibroblasts to ionizing radiation[J]. Oncogene, 1995, 10(12):2403-2408.

[17]

Vozenin MC, Lord HK, Hartl D, et al. Unravelling the biology of human papillomavirus(HPV) related tumours to enhance their radiosensitivity[J]. Cancer Treat Rev, 2010, 36(8):629-636. DOI:10.1016/j.ctrv.2010.03.010.

[18]

Malik A, Sultana M, Qazi A, et al. Role of natural radiosensitizers and cancer Cell Radioresistance: An Update[J/OL]. Anal Cell Pathol (Amst), 2016, 2016: 6146595[2016-03-01]. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4779816. DOI: 10.1155/2016/6146595.

[19]

Kim W, Youn H, Kang C, et al. Inflammation-induced radioresistance is mediated by ROS-dependent inactivation of protein phosphatase 1 in non-small cell lung cancer cells[J]. Apoptosis, 2015, 20(9):1242-1252. DOI:10.1007/s10495-015-1141-1.

[20]

Chen YH, Pan SL, Wang JC, et al. Radiation-induced VEGF-C expression and endothelial cell proliferation in lung cancer[J]. Strahlenther Onkol, 2014, 190(12):1154-1162. DOI:10.1007/s00066-014-0708-z.

[21]

Fu ZZ, Sun XD, Li P, et al. Relationship between serum VEGF level and radiosensitivity of patients with nonsmall cell lung cancer among asians:a meta-analysis[J]. DNA Cell Biol, 2014, 33(7):426-437. DOI:10.1089/dna.2013.2249.

[22]

Tang Y, Liu B, Li J, et al. Genetic variants in PI3K/AKT pathway are associated with severe radiation pneumonitis in lung cancer patients treated with radiation therapy[J]. Cancer Med, 2016, 5(1):24-32. DOI:10.1002/cam4.564.

[23]

Lei Y, Li HX, Jin WS, et al. The radiosensitizing effect of Paeonol on lung adenocarcinoma by augmentation of radiation-induced apoptosis and inhibition of the PI3K/Akt pathway[J]. Int J Radiat Biol, 2013, 89(12):1079-1086. DOI:10.3109/09553002.2013.825058.